Correlation Between Antibe Therapeutics and Oxford Nanopore

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Antibe Therapeutics and Oxford Nanopore at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Antibe Therapeutics and Oxford Nanopore into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Antibe Therapeutics and Oxford Nanopore Technologies, you can compare the effects of market volatilities on Antibe Therapeutics and Oxford Nanopore and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Antibe Therapeutics with a short position of Oxford Nanopore. Check out your portfolio center. Please also check ongoing floating volatility patterns of Antibe Therapeutics and Oxford Nanopore.

Diversification Opportunities for Antibe Therapeutics and Oxford Nanopore

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Antibe and Oxford is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Antibe Therapeutics and Oxford Nanopore Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oxford Nanopore Tech and Antibe Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Antibe Therapeutics are associated (or correlated) with Oxford Nanopore. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oxford Nanopore Tech has no effect on the direction of Antibe Therapeutics i.e., Antibe Therapeutics and Oxford Nanopore go up and down completely randomly.

Pair Corralation between Antibe Therapeutics and Oxford Nanopore

If you would invest  113.00  in Oxford Nanopore Technologies on September 23, 2024 and sell it today you would earn a total of  71.00  from holding Oxford Nanopore Technologies or generate 62.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Antibe Therapeutics  vs.  Oxford Nanopore Technologies

 Performance 
       Timeline  
Antibe Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Antibe Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Antibe Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Oxford Nanopore Tech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oxford Nanopore Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Oxford Nanopore is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Antibe Therapeutics and Oxford Nanopore Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Antibe Therapeutics and Oxford Nanopore

The main advantage of trading using opposite Antibe Therapeutics and Oxford Nanopore positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Antibe Therapeutics position performs unexpectedly, Oxford Nanopore can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oxford Nanopore will offset losses from the drop in Oxford Nanopore's long position.
The idea behind Antibe Therapeutics and Oxford Nanopore Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.